Gastroparesis Treatment Market is Estimated to Witness Growth Owing to Rising Prevalence of Gastroparesis

Gastroparesis refers to delayed gastric emptying that is a disorder where the stomach takes too long to empty its contents. It is a long-term condition where the nerves and muscles in the stomach and small intestines are damaged, resulting in reduced gastric motility. The main symptoms include nausea, vomiting of undigested food, abdominal fullness, and early satiety. 

Gastroparesis requires a variety of medications and procedures to control symptoms. Metoclopramide and domperidone are the first line of treatment for gastroparesis to speed up gastric emptying. For patients with severe symptoms that do not improve, surgical procedures such as gastric neurostimulation and pyloroplasty may be considered.  

Global gastroparesis treatment market is estimated to be valued at USD 7.95 Bn in 2024 and is expected to reach USD 10.91 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031. 

Key Takeaways 

Key players operating in the gastroparesis treatment market are Evoke Pharma, Inc., Processa 

Pharmaceuticals, Inc., Neurogastrx, Inc., Vanda Pharmaceuticals Inc., ANI Pharmaceuticals, 

Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Otsuka Holdings Co.,

Ltd., CinDome Pharma, Inc., PTC Therapeutics, Pfizer, Inc., Teva Pharmaceutical Industries 

Ltd., Atlantic Healthcare, Salix Pharmaceuticals, Rhythm Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Medtronic plc, Bausch Health Companies Inc., Sanofi S.A. Increasing healthcare expenditure has opened promising opportunities for key players to develop advanced therapeutics for gastroparesis treatment.

The Gastroparesis Treatment Market share is also expanding globally due to rising awareness regarding gastroparesis disorders and increasing healthcare expenditure. For instance, many developing countries are witnessing rising incidences of gastroparesis due to lifestyle changes and diet patterns.

Market Drivers 

The rising prevalence of diabetes and other gastrointestinal disorders that cause delayed gastric emptying are major market drivers. According to the National Institutes of Health (NIH), the prevalence of gastroparesis in the total population is estimated to be 0.5-3%. However, it is more prevalent in people with diabetes and females. Furthermore, the growing geriatric population who is more susceptible to such conditions will augment the demand. In addition, the increasing approval of newer therapeutics and pipeline drugs will accelerate the industry expansion through 2031. 

PEST Analysis  

Political: The gastroparesis treatment market is subject to regulations from the FDA regarding approval of new drugs and medical devices. Regulations affect the time to market for new treatments.  

Economic: The rising healthcare costs in major markets are putting pressure on payers to control costs. Payers prefer low-cost generic drugs over expensive branded drugs which can impact the demand for newer treatments.  

Social: Growing awareness among patients about newer treatment options is driving the demand for effective therapies. Support groups help improve understanding of gastroparesis and available treatment options.  

Technological: Advancements in drug delivery mechanisms and the integration of technologies like sensors are enhancing treatment effectiveness. Research into causes of gastroparesis at molecular level can lead to targeted therapies.  

The United States represents the largest geographical market for gastroparesis treatment in terms of value currently. Wide product availability, sophisticated healthcare infrastructure, and higher adoption of expensive treatments contribute to its dominant position.  

The Asia Pacific region is poised to be the fastest growing regional market during the forecast period. Rising healthcare expenditure, growing patient pool driven by changing lifestyles and diet, increasing product launches are fueling market growth in the region. Countries like China and India with their huge population bases offer high potential for market expansion. 

Get More Insights On Gastroparesis Treatment Market

Get this Report in Japanese Language

胃不全麻痺治療市場

Get this Reports in korean Language

위장 마비 치료 시장

 About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/ )